최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국호스피스·완화의료학회지 = Korean journal of hospice and palliative care, v.20 no.2, 2017년, pp.81 - 92
신진영 , 박혜윤 (성균관대학교 의과대학, 삼성서울병원 내과학교실 호흡기내과) , 이정권 (성균관대학교 의과대학, 삼성의료원 암치유센터)
Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation that is usually progressive. It is a major cause of morbidity and mortality worldwide, leading to substantial and increasing economic and social burden. Palliative care for COPD patients aims to reduce sym...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
만성 폐쇄성 폐질환의 특징은 무엇인가 | 만성 폐쇄성 폐질환은 비가역적, 점진적 기도 폐쇄가 특징인 주요 사망 원인중의 하나이다. 말기 폐쇄성 폐질환 환자는 다양한 신체적, 정서적, 사회적, 기능적 문제로 인해 호스피스 완화의료가 필요하다. | |
환자연명의료결정법의 목적은 무엇인가? | 지난 2016년 2월 3일 ‘호스피스 완화의료 및 임종과정에 있는 환자의 연명의료결정에 관한 법률’, 약칭 환자연명의료결정법이 제정되었으며 2017년 8월 4일 시행을 앞두고 있다. 이 법령은 호스피스 완화의료와 임종 과정에 있는 환자의 연명의료와 연명의료중단 등을 결정하고 이행하는 데 필요한 사항을 규정함으로써 환자의 최선의 이익을 보장하고 자기결정권을 존중하여 인간으로서의 존엄과 가치를 보호하는 목적으로 제정되었다. 특징적으로, 암 이외에도 후천성면역결핍증, 만성폐쇄성 호흡기질환, 만성 간경화 및 그 밖에 보건복지부령으로 정하는 질환이 호스피스 완화의료 대상 질환으로 확대되었다. | |
호스피스 완화의료 대상 질환에는 어떤 것들이 있는가? | 이 법령은 호스피스 완화의료와 임종 과정에 있는 환자의 연명의료와 연명의료중단 등을 결정하고 이행하는 데 필요한 사항을 규정함으로써 환자의 최선의 이익을 보장하고 자기결정권을 존중하여 인간으로서의 존엄과 가치를 보호하는 목적으로 제정되었다. 특징적으로, 암 이외에도 후천성면역결핍증, 만성폐쇄성 호흡기질환, 만성 간경화 및 그 밖에 보건복지부령으로 정하는 질환이 호스피스 완화의료 대상 질환으로 확대되었다. 이에 따라, 담당의사와 해당 분야의 전문의 1명으로부터 수개월 이내에 사망할 것으로 예상되는 비암성 말기환자도 호스피스 완화의료 대상자이다. |
Seamark DA, Seamark CJ, Halpin DM. Palliative care in chronic obstructive pulmonary disease: a review for clinicians. J R Soc Med 2007;100:225-33.
GOLD: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [Internet]. [Place of publication not identified]: Global Initiative for Chronic Obstructive Lung Disease; c2016 [updated 2016; cited 2016 Jul 1]. Available from: http://www.goldcopd.org.
Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.
KCDC: 2015 The prevalance of chronic obstructive pulmonary disease [Internet]. Cheongju: Division of Health & Nutrtition Survey, Centers for Disease Control & Prevention; 2016 [cited 2016 Jul 1]. Available from: https://knhanes.cdc.go.kr/knhanes/index.do.
U.S. Department of Health and Human Services, Public Health Service, Office of the Surgeon Genernal. The health consequences of smoking-50 years of progress: a report of the Surgeon General. Atlanta, GA.:U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health;2014.
Yoo KH. Smoking cessation and chronic obstructive pulmonary disease. Korean J Intern Med 2015;30:163-6.
Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009;33:1165-85.
Au DH, Udris EM, Fihn SD, McDonell MB, Curtis JR. Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer. Arch Intern Med 2006;166:326-31.
Rocker G, Horton R, Currow D, Goodridge D, Young J, Booth S. Palliation of dyspnoea in advanced COPD: revisiting a role for opioids. Thorax 2009;64:910-5.
Zhou HX, Ou XM, Tang YJ, Wang L, Feng YL. Advanced Chronic Obstructive Pulmonary Disease: Innovative and Integrated Management Approaches. Chin Med J (Engl) 2015;128:2952-9.
Weingaertner V, Scheve C, Gerdes V, Schwarz-Eywill M, Prenzel R, Bausewein C, et al. Breathlessness, functional status, distress, and palliative care needs over time in patients with advanced chronic obstructive pulmonary disease or lung cancer: a cohort study. J Pain Symptom Manage 2014;48:569-81.e1.
Ostgathe C, Alt-Epping B, Golla H, Gaertner J, Lindena G, Radbruch L, et al. Non-cancer patients in specialized palliative care in Germany: what are the problems? Palliat Med 2011;25:148-52.
van der Eerden M, Csikos A, Busa C, Hughes S, Radbruch L, Menten J, et al. Experiences of patients, family and professional caregivers with Integrated Palliative Care in Europe: protocol for an international, multicenter, prospective, mixed method study. BMC Palliat Care 2014;13:52.
Hess S, Stiel S, Hofmann S, Klein C, Lindena G, Ostgathe C. Trends in specialized palliative care for non-cancer patients in Germany--data from the national hospice and palliative care evaluation (HOPE). Eur J Intern Med 2014;25:187-92.
Rosenwax L, Spilsbury K, McNamara BA, Semmens JB. A retrospective population based cohort study of access to specialist palliative care in the last year of life: who is still missing out a decade on? BMC Palliat Care 2016;15:46.
Bettoncelli G, Blasi F, Brusasco V, Centanni S, Corrado A, De Benedetto F, et al. The clinical and integrated management of COPD. An official document of AIMAR (Interdisciplinary Association for Research in Lung Disease), AIPO (Italian Association of Hospital Pulmonologists), SIMER (Italian Society of Respiratory Medicine), SIMG (Italian Society of General Medicine). Multidiscip Respir Med 2014;9:25.
West E, Pasman HR, Galesloot C, Lokker ME, Onwuteaka-Philipsen B; EURO IMPACT. Hospice care in the Netherlands: who applies and who is admitted to inpatient care? BMC Health Serv Res 2016;16:33.
Higginson IJ, Bausewein C, Reilly CC, Gao W, Gysels M, Dzingina M, et al. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Respir Med 2014;2:979-87.
Korean Academy of Medical Sciences. The standardization of definition for end of life and the last days of life [Internet]. Seoul: Korean Academy of Medical Sciences; 2016. [cited 2017 Apr 20]. Availble from: http://hospice.cancer.go.kr/hospice/front/boardView.do?keykind&keyword&page_now&returl/front/boardList.do&listurl/front/boardList.do&brd_mgrno181&menu_n o442&brd_no88471.
Lanken PN, Terry PB, Delisser HM, Fahy BF, Hansen-Flaschen J, Heffner JE, et al. An Official American Thoracic Society Clinical Policy Statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med 2008;177:912-27.
Dalgaard KM, Bergenholtz H, Nielsen ME, Timm H. Early integration of palliative care in hospitals: A systematic review on methods, barriers, and outcome. Palliat Support Care 2014;12:495-513.
Siouta N, van Beek K, Preston N, Hasselaar J, Hughes S, Payne S, et al. Towards integration of palliative care in patients with chronic heart failure and chronic obstructive pulmonary disease: a systematic literature review of European guidelines and pathways. BMC Palliat Care 2016;15:18.
Blinderman CD, Homel P, Billings JA, Tennstedt S, Portenoy RK. Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease. J Pain Symptom Manage 2009;38:115-23.
Weingartner V, Scheve C, Gerdes V, Schwarz-Eywill M, Prenzel R, Otremba B, et al. Characteristics of episodic breathlessness as reported by patients with advanced chronic obstructive pulmonary disease and lung cancer: Results of a descriptive cohort study. Palliat Med 2015;29:420-8.
Vestbo J, Anderson JA, Calverley PM, Celli B, Ferguson GT, Jenkins C, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64:939-43.
Rocker G, Horton R, Currow D, Goodridge D, Young J, Booth S. Palliation of dyspnoea in advanced COPD: revisiting a role for opioids. Thorax 2009;64:910-5.
National Clinical Guideline Centre. Chronic obstructive pulmonary disease: Management of chronic obstructive pulmonaty disease in adults in primary and secondary care [Internet]. London: Royal College of Physicians (UK); 2010. National Institute for Health and Clinical Excellence. NICE Clinical Guidelines, No. 101. [updated 2016 Jun; cited 2016]. Available from: https://www.nice.org.uk/guidance/cg101/resources/chronic-obstructive-pulmonary-disease-update-full-guideline2.
Albert RK, Connett J, Bailey WC, Casaburi R, Cooper JA Jr, Criner GJ, et al. Azithromycin for prevention of exacerbations of COPD. N Engl J Med 2011;365:689-98.
Martinez FJ, Calverley PM, Goehring UM, Brose M, Fabbri LM, Rabe KF. Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial. Lancet 2015;385:857-66.
Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med 1980;93:391-8.
Jennings AL, Davies AN, Higgins JP, Gibbs JS, Broadley KE. A systematic review of the use of opioids in the management of dyspnoea. Thorax 2002;57:939-44.
Varkey B. Opioids for palliation of refractory dyspnea in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med 2010;16:150-4.
Heffner JE. Advance care planning in chronic obstructive pulmonary disease: barriers and opportunities. Curr Opin Pulm Med 2011;17:103-9.
Hardin KA, Meyers F, Louie S. Integrating palliative care in severe chronic obstructive lung disease. COPD 2008;5:207-20.
Creutzberg EC, Wouters EF, Mostert R, Weling-Scheepers CA, Schols AM. Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease. Nutrition 2003;19:120-7.
Leuppi JD, Schuetz P, Bingisser R, Bodmer M, Briel M, Drescher T, et al. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA 2013;309:2223-31.
IMPRESS guide for commissioners on supportive and end of life care for people with COPD. London;Warwickshire: British Thoracic Society and Primary Care Respiratory Society UK;2012.
Mas A, Masip J. Noninvasive ventilation in acute respiratory failure. Int J Chron Obstruct Pulmon Dis 2014;9:837-52.
Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax 2000;55:1000-6.
Sillen MJ, Franssen FM, Delbressine JM, Vaes AW, Wouters EF, Spruit MA. Efficacy of lower-limb muscle training modalities in severely dyspnoeic individuals with COPD and quadriceps muscle weakness: response from the authors. Thorax 2014;69:953-4.
Downar J, Delaney JW, Hawryluck L, Kenny L. Guidelines for the withdrawal of life-sustaining measures. Intensive Care Med 2016;42:1003-17.
Connors AF Jr, Dawson NV, Thomas C, Harrell FE Jr, Desbiens N, Fulkerson WJ, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 1996;154(4 Pt 1):959-67.
Hoogendoorn M, Hoogenveen RT, Rutten-van Molken MP, Vestbo J, Feenstra TL. Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach. Eur Respir J 2011;37:508-15.
Roberts CM, Lowe D, Bucknall CE, Ryland I, Kelly Y, Pearson MG. Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease. Thorax 2002;57:137-41.
Glaudemans JJ, Moll van Charante EP, Willems DL. Advance care planning in primary care, only for severely ill patients? A structured review. Fam Pract 2015;32:16-26.
Roberts JE, Reid MC, Adelman RD. Palliative care interventions in advanced chronic diseases: A systematic review. J Am Geriatr Soc 2012;60(s4):S226.
Rocker GM, Simpson AC, Horton R. Palliative care in advanced lung disease: The challenge of integrating palliation Into everyday care. Chest 2015;148:801-9.
Croft M. Palliative care in end-stage COPD. Br J Gen Pract 2005;55:234.
Curtis JR. Palliative and end-of-life care for patients with severe COPD. Eur Respir J 2008;32:796-803.
Curtis JR, Wenrich MD, Carline JD, Shannon SE, Ambrozy DM, Ramsey PG. Patients' perspectives on physician skill in end-of-life care: differences between patients with COPD, cancer, and AIDS. Chest 2002;122:356-62.
Gaber KA, Barnett M, Planchant Y, McGavin CR. Attitudes of 100 patients with chronic obstructive pulmonary disease to artificial ventilation and cardiopulmonary resuscitation. Palliat Med 2004;18:626-9.
Carlucci A, Vitacca M, Malovini A, Pierucci P, Guerrieri A, Barbano L, et al. End-of-life discussion, patient understanding and determinants of preferences in very severe COPD patients: A multicentric study. Copd 2016;13:632-8.
Fromer L. Implementing chronic care for COPD: planned visits, care coordination, and patient empowerment for improved outcomes. Int J Chron Obstruct Pulmon Dis 2011;6:605-14.
Ouwens M, Wollersheim H, Hermens R, Hulscher M, Grol R. Integrated care programmes for chronically ill patients: a review of systematic reviews. Int J Qual Health Care 2005;17:141-6.
Garralda E, Hasselaar J, Carrasco JM, Van Beek K, Siouta N, Csikos A, et al. Integrated palliative care in the Spanish context: a systematic review of the literature. BMC Palliat Care 2016;15:49.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.